Vanda Pharmaceuticals (VNDA) Change in Taxes (2010 - 2011)
Vanda Pharmaceuticals (VNDA) posted Change in Taxes of -$2.1 million for Q4 2011, down 1765.49% sequentially from -$113000.0 in Q3 2011, and down 417.95% YoY from $663000.0 in Q4 2010.
Powered by 
Analysis
Vanda Pharmaceuticals (VNDA) Change in Taxes (2010 - 2011) Analysis & Trends
Vanda Pharmaceuticals has reported Change in Taxes for 2 years, with the latest figure at -$2.1 million in Q4 2011.
- Quarterly Change in Taxes fell 417.95% year-over-year to -$2.1 million in Q4 2011, while the trailing twelve-month figure through Dec 2011 was -$2.3 million (changed N/A YoY) and the FY2011 annual result came in at -$2.3 million, down 158.13% from the prior year.
- Change in Taxes fell to -$2.1 million in Q4 2011 per VNDA's latest filing, from -$113000.0 in the prior quarter.
- Over five years, Change in Taxes peaked at $663000.0 in Q4 2010 and troughed at -$2.5 million in Q3 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Vanda Pharmaceuticals | 327.03 Mn | 157.00 Mn | 46.97 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2011 | -2.11 Mn |
| Sep 30, 2011 | -113,000.00 |
| Jun 30, 2011 | -51,000.00 |
| Mar 31, 2011 | 6,000.00 |
| Dec 31, 2010 | 663,000.00 |
| Sep 30, 2010 | -2.53 Mn |